<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2023-024</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-7406</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЦЕРЕБРОВАСКУЛЯРНЫЕ ЗАБОЛЕВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CEREBROVASCULAR DISEASES</subject></subj-group></article-categories><title-group><article-title>Участие иммунного ответа в патогенезе ишемического инсульта</article-title><trans-title-group xml:lang="en"><trans-title>Involvement immune response in the pathogenesis of ischemic stroke</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4830-907X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьев</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorobyev</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Воробьев Сергей Владимирович доктор медицинских наук, главный научный сотрудник научно-исследовательской лаборатории неврологии и нейрореабилитации, НМИЦ имени В.А. Алмазова; профессор кафедры клинической лабораторной диагностики, Санкт-Петербургский ГПМУ.</p><p>197341, Санкт-Петербург, ул. Аккуратова, д. 2; 194100, Санкт-Петербург, ул. Литовская, д. 2</p></bio><bio xml:lang="en"><p>Sergey V. Vorobyev - Dr. Sci. (Med.), Chief Researcher Laboratory of Neurology and Neurorehabilitation, Almazov NMRC; Professor of the Department of Clinical Laboratory Diagnostics, St Petersburg SPMU.</p><p>2, Akkuratov St., St Petersburg, 197341; 2, Litovskaya St., St Petersburg, 194100</p></bio><email xlink:type="simple">sergiognezdo@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6484-286X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Янишевский</surname><given-names>С. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Yanishevskiy</surname><given-names>S. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Янишевский Станислав Николаевич доктор медицинских наук, заведующий научно-исследовательской лабораторией неврологии и нейрореабилитации, НМИЦ имени В.А. Алмазова; доцент кафедры нервных болезней, Военно-медицинская академия имени С.М. Кирова.</p><p>197341, Санкт-Петербург, ул. Аккуратова, д. 2; 194044, Санкт-Петербург, ул. Академика Лебедева, д. 6</p></bio><bio xml:lang="en"><p>Stanislav N. Yanishevskiy - Dr. Sci. (Med.), Head of the Laboratory of Neurology and Neurorehabilitation, Almazov NMRC; Associate Professor of the Department of Nervous Diseases, MMA named after S.M. Kirov.</p><p>2, Akkuratov St., St Petersburg, 197341; 6, Akademik Lebedev St., St Petersburg, 194044</p></bio><email xlink:type="simple">stasya71@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7204-7850</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кудрявцев</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kudriavtsev</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кудрявцев Игорь Владимирович - кандидат биологических наук, заведующий лабораторией клеточной иммунологии, Институт экспериментальной медицины; старший научный сотрудник НИЛ аутоиммунных и аутовоспалительных заболеваний Научного центра мирового уровня «Центр персонализированной медицины», НМИЦ имени В.А. Алмазова; доцент кафедры иммунологии, Первый Санкт-Петербургский ГМУ имени академика И.П. Павлова.</p><p>197341, Санкт-Петербург, ул. Аккуратова, д. 2; 197376, Санкт-Петербург, ул. Академика Павлова, д. 12; 197022, Санкт-Петербург, ул. Льва Толстого, д. 6-8</p></bio><bio xml:lang="en"><p>Igor V. Kudriavtsev - Cand. Sci (Biol.), Head of the Laboratory of Cellular Immunology, Institute of Experimental Medicine; Senior Researcher Research Laboratory of Autoimmune and Autoinflammatory Diseases, Almazov NMRC; Associate Professor of the Department of Immunology, Pavlov First Saint Petersburg SMU.</p><p>2, Akkuratov St., St Petersburg, 197341; 12, Academician Pavlova St., St Petersburg, 197376; 6-8, Lev Tolstoy St., St Petersburg, 197022</p></bio><email xlink:type="simple">igorek1981@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7336-3860</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шубина</surname><given-names>К. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Shubina</surname><given-names>K. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шубина Кристина Максимовна врач-невролог неврологического отделения, Городская Покровская больница.</p><p>199106, Санкт-Петербург, Большой проспект Васильевского острова, д. 85</p></bio><bio xml:lang="en"><p>Kristina M. Shubina - Neurologist of the Neurological Department, City Pokrovskaya Hospital.</p><p>85, Bolshoy Prospekt of Vasilievsky Island, St Petersburg, 199106</p></bio><email xlink:type="simple">krisschubina@yandex.ru</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4456-0398</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Антушева</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Antusheva</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Антушева Мария Сергеевна студентка Института медицинского образования.</p><p>197341, Санкт-Петербург, ул. Аккуратова, д. 2</p></bio><bio xml:lang="en"><p>Maria S. Antusheva - Student of the Institute of Medical Education.</p><p>2, Akkuratov St., St Petersburg, 197341</p></bio><email xlink:type="simple">mariantusheva@gmail.com</email><xref ref-type="aff" rid="aff-5"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4932-6733</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузнецова</surname><given-names>Р. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuznetsova</surname><given-names>R. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кузнецова Раиса Николаевна - кандидат медицинских наук, доцент, доцент кафедры иммунологии, Первый Санкт-Петербургский ГМУ имени академика И.П. Павлова; врач аллерголог-иммунолог медицинского центра, Санкт-Петербургский НИИЭМ им. Пастера.</p><p>197022, Санкт-Петербург, ул. Льва Толстого, д. 6-8; 197101, Санкт-Петербург, ул. Мира, д. 14</p></bio><bio xml:lang="en"><p>Raisa N. Kuznetsova - Cand. Sci. (Med.), Associate Professor of the Department of Immunology Pavlov First Saint PSMU; Allergisti mmunologist of the Medical Center, Saint-Petersburg PI.</p><p>6-8, Lev Tolstoy St., St Petersburg, 197022; 14, Mira St., St Petersburg, 197101</p></bio><email xlink:type="simple">kuznetzova.rais@yandex.ru</email><xref ref-type="aff" rid="aff-6"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2596-4220</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Серебрякова</surname><given-names>М. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Serebriakova</surname><given-names>M. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Серебрякова Мария Константиновна научный сотрудник лаборатории общей иммунологии, Институт экспериментальной медицины.</p><p>197376, Санкт-Петербург, ул. Академика Павлова, д. 12</p></bio><bio xml:lang="en"><p>Maria K. Serebriakova - Research Officer Laboratories of General Immunology, Institute of Experimental Medicine.</p><p>12, Academician Pavlova St., St Petersburg, 197376</p></bio><email xlink:type="simple">m-serebryakova@yandex.ru</email><xref ref-type="aff" rid="aff-7"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5918-7450</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петухова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Petukhova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петухова Ольга Владимировна врач-невролог, Городская больница № 40.</p><p>197706, Санкт-Петербург, Сестрорецк, ул. Борисова, д. 9</p></bio><bio xml:lang="en"><p>Olga V. Petukhova – Neurologist.</p><p>9, Borisov St., Sestroretsk, St Petersburg, 197706</p></bio><email xlink:type="simple">olya.petuchova84@mail.ru</email><xref ref-type="aff" rid="aff-8"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр имени В.А. Алмазова; Санкт-Петербургский государственный педиатрический медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Centre; St Petersburg State Pediatric Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр имени В.А. Алмазова; Военно-медицинская академия имени С.М. Кирова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Centre; Military Medical Academy named after S.M. Kirov</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр имени В.А. Алмазова; Институт экспериментальной медицины; Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Centre; Institute of Experimental Medicine; Pavlov First Saint Petersburg State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Городская Покровская больница</institution><country>Россия</country></aff><aff xml:lang="en"><institution>City Pokrovskaya Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-5"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр имени В.А. Алмазова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Almazov National Medical Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-6"><aff xml:lang="ru"><institution>Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова; Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии имени Пастера</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pavlov First Saint Petersburg State Medical University; Saint-Petersburg Pasteur Institute</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-7"><aff xml:lang="ru"><institution>Институт экспериментальной медицины</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Experimental Medicine</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-8"><aff xml:lang="ru"><institution>Городская больница № 40</institution><country>Россия</country></aff><aff xml:lang="en"><institution>City Hospital No. 40</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>10</day><month>04</month><year>2023</year></pub-date><volume>0</volume><issue>3</issue><fpage>8</fpage><lpage>16</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Воробьев С.В., Янишевский С.Н., Кудрявцев И.В., Шубина К.М., Антушева М.С., Кузнецова Р.Н., Серебрякова М.К., Петухова О.В., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Воробьев С.В., Янишевский С.Н., Кудрявцев И.В., Шубина К.М., Антушева М.С., Кузнецова Р.Н., Серебрякова М.К., Петухова О.В.</copyright-holder><copyright-holder xml:lang="en">Vorobyev S.V., Yanishevskiy S.N., Kudriavtsev I.V., Shubina K.M., Antusheva M.S., Kuznetsova R.N., Serebriakova M.K., Petukhova O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/7406">https://www.med-sovet.pro/jour/article/view/7406</self-uri><abstract><p>Острые нарушения мозгового кровообращения являются одной из ведущих проблем современной клинической медицины, что обусловлено их значительным распространением в человеческой популяции и крайне негативным влиянием, оказываемым на организм пациента. Имеющиеся в настоящее время данные позволяют говорить о многовекторном характере патогенеза ишемического повреждения головного мозга. В рамках каскада развивающихся патохимических и патофизиологических процессов существенная роль в формировании ишемического инсульта принадлежит воспалительной реакции, протекающей посредством ответа иммунной системы на ишемию мозговой ткани. Одним из мест его реализации является стенка сосуда, находящегося в зоне ишемии, где при помощи белков клеточной адгезии происходит привлечение моноцитов и нейтрофилов. Значительную роль играет активация комплемента, осуществляемая в основном за счет С3 компонента или при инициализации маннозного пути. Непосредственно в очаге ишемии огромная роль принадлежит активации микроглии и астроцитов. При этом необходимо отметить, что в процессе активации как микроглия, так и астроциты способны приобретать провоспалительный или противовоспалительный фенотип. Превалирование провоспалительного варианта способствует пролонгированному повреждению ткани головного мозга, в то время как преобладание противовоспалительного фенотипа оказывает протективный эффект. Большую роль играет нарушение функции гематоэнцефалического барьера, что обеспечивает дополнительный приток лейкоцитов к месту ишемии. Кроме того, отдельные субпопуляции Т-лимфоцитов, проникающие через поврежденный барьер, также имеют существенное значение в организации и динамике иммуновоспалительного ответа. Наиболее изучено действие Th1 и Th2 клеток, гамма-дельта Т-лимфоцитов, естественных клеток-киллеров, а также регуляторных Т-лимфоцитов. Рассматривается роль В-лимфоцитов в формировании очага инсульта.</p></abstract><trans-abstract xml:lang="en"><p>Acute disorders of cerebral circulation are one of the leading problems of modern clinical medicine, due to their significant spread in the human population and the extremely negative impact exerted on the patient’s body. Currently available data allow us to talk about the multi-vector nature of the pathogenesis of ischemic brain damage. Within the framework of the cascade of developing pathochemical and pathophysiological processes, an essential role in the formation of ischemic stroke belongs to the inflammatory reaction occurring through the immune system’s response to cerebral tissue ischemia. One of the places of its implementation is the vessel wall located in the ischemic zone, where monocytes and neutrophils are attracted with the help of cell adhesion proteins. Complement activation plays a significant role, carried out mainly due to the C3 component or during the initialization of the mannose pathway. Activation of microglia and astrocytes plays a huge role directly in the focus of ischemia. It should be noted that in the process of activation, both microglia and astrocytes are able to acquire a pro-inflammatory or anti-inflammatory phenotype. The prevalence of the pro-inflammatory variant contributes to prolonged damage to brain tissue, while the predominance of the anti-inflammatory phenotype has a protective effect. An important role is played by a violation of the function of the blood-brain barrier, which provides an additional influx of leukocytes to the site of ischemia. In addition, individual subpopulations of T-lymphocytes penetrating through the damaged barrier also play a significant role in the organization and dynamics of the immuno-inflammatory response. The action of Th1 and Th2 cells, gamma-delta T lymphocytes, natural killer cells, as well as regulatory T lymphocytes has been most studied. The role of B-lymphocytes in the formation of a stroke focus is considered.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инсульт</kwd><kwd>иммунный ответ</kwd><kwd>микроглия</kwd><kwd>астроциты</kwd><kwd>ишемия</kwd><kwd>гематоэнцефалический барьер</kwd><kwd>Т-лимфоциты</kwd><kwd>цитокины</kwd></kwd-group><kwd-group xml:lang="en"><kwd>stroke</kwd><kwd>immune response</kwd><kwd>microglia</kwd><kwd>astrocytes</kwd><kwd>ischemia</kwd><kwd>blood-brain barrier</kwd><kwd>T-lymphocytes</kwd><kwd>cytokines</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Стародубцева О.С., Бегичева С.В. Анализ заболеваемости инсультом с использованием информационных технологий. Фундаментальные исследования. 2012;8(2):424-427. Режим доступа: https://fundamental-research.ru/ru/article/view?id=30383.</mixed-citation><mixed-citation xml:lang="en">Starodubceva O.S., Begicheva S.V. Analysis of stroke incidence of the use of information technologies. Fundamental Research. 2012;8(2):424-427. (In Russ.) Available at: https://fundamentaL-research.ru/ru/articLe/view?id=30383.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Стаховская Л.В., Клочихина О.А., Богатырева М.Д., Коваленко В.В. Эпидемиология инсульта в России по результатам территориально-популяционного регистра (2009 2010). Журнал неврологии и психиатрии им. С.С. Корсакова. 2013;113(5):4-10. Режим доступа: https://www.mediasphera.ru/issues/zhumal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2013/5/031997-7298201351.</mixed-citation><mixed-citation xml:lang="en">Stakhovskaya L.V., KLochikhina O.A., Bogatyreva M.D., KovaLenko V.V. EpidemioLogy of stroke in the Russian Federation: resuLts of territory's popuLation registry (2009-2010). Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2013;113(5):4-10. (In Russ.) AvaiLabLe at: https://www.mediasphera.ru/issues/zhurnaL-nevroLogii-i-psikhiatrii-im-s-s-korsakova/2013/5/031997-7298201351.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Пирадов М.А., Максимова М.Ю., Домашенко М.А. Инсульт: пошаговая инструкция. М.: ГЭОТАР-Медиа; 2019. 272 с. Режим доступа: https://www.labirint.ru/books/679266/.</mixed-citation><mixed-citation xml:lang="en">Piradov M.A., Maksimova M.Y., Domashenko M.A. Stroke: Step-by-step instructions. Moscow: GEOTAR-Media; 2019. 272 p. (In Russ.) AvaiLabLe at: https://www.Labirint.ru/books/679266/.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Hall MJ., levant S., DeFrances CJ. Hospitalization for stroke in U.S. hospitals, 1989-2009. NCHS Data Brief. 2012;(95):1-8. Available at: https://www.cdc.gov/nchs/data/databriefs/db95.pdf.</mixed-citation><mixed-citation xml:lang="en">HaLL MJ., Levant S., DeFrances CJ. HospitaLization for stroke in U.S. hospitaLs, 1989-2009. NCHS Data Brief. 2012;(95):1-8. AvaiLabLe at: https://www.cdc.gov/nchs/data/databriefs/db95.pdf.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin EJ., Berry J.D., Borden W.B. et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2-e220. https://doi.org/10.1161/CIR.0b013e31823ac046.</mixed-citation><mixed-citation xml:lang="en">Roger V.L., Go A.S., LLoyd-Jones D.M., Benjamin EJ., Berry J.D., Borden W.B. et aL. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2-e220. https://doi.org/10.1161/CIR.0b013e31823ac046.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tsivgoulis G., Psaltopoulou T., Wadley V.G., Alexandrov A.V., Howard G., Unverzagt F.W. et al. Adherence to a Mediterranean diet and prediction of incident stroke. Stroke. 2015;46(3):780-785. https://doi.org/10.1161/STROKEAHA.114.007894.</mixed-citation><mixed-citation xml:lang="en">TsivgouLis G., PsaLtopouLou T., WadLey V.G., ALexandrov A.V., Howard G., Unverzagt F.W. et aL. Adherence to a Mediterranean diet and prediction of incident stroke. Stroke. 2015;46(3):780-785. https://doi.org/10.1161/STROKEAHA.114.007894.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Howard G., Goff D.C. Population shifts and the future of stroke: forecasts of the future burden of stroke. Ann N Y Acad Sci. 2012;1268:14-20. https://doi.org/10.1111/j.1749-6632.2012.06665.x.</mixed-citation><mixed-citation xml:lang="en">Howard G., Goff D.C. PopuLation shifts and the future of stroke: forecasts of the future burden of stroke. Ann N Y Acad Sci. 2012;1268:14-20. https://doi.org/10.1111/j.1749-6632.2012.06665.x.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chamorro A., Meisel A., Planas A.M., Urra X., van de Beek D., Veltkamp R. The immunology of acute stroke. Nat Rev Neurol. 2012;8(7):401-410. https://doi.org/10.1038/nrneurol.2012.98.</mixed-citation><mixed-citation xml:lang="en">Chamorro A., MeiseL A., PLanas A.M., Urra X., van de Beek D., VeLtkamp R. The immunoLogy of acute stroke. Nat Rev Neurol. 2012;8(7):401-410. https://doi.org/10.1038/nrneuroL.2012.98.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">De Meyer S.F., Denorme F., langhauser F., Geuss E., Fluri F., Kleinschnitz C. Thromboinflammation in stroke brain damage. Stroke. 2016;47(4):1165-1172. https://doi.org/10.1161/STROKEAHA.115.011238.</mixed-citation><mixed-citation xml:lang="en">De Meyer S.F., Denorme F., Langhauser F., Geuss E., FLuri F., KLeinschnitz C. ThromboinfLammation in stroke brain damage. Stroke. 2016;47(4):1165-1172. https://doi.org/10.1161/STROKEAHA.115.011238.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Delvaeye M., Conway E.M. Coagulation and innate immune responses: can we view them separately? Blood. 2009;114(12):2367-2374. https://doi.org/10.1182/blood-2009-05-199208.</mixed-citation><mixed-citation xml:lang="en">DeLvaeye M., Conway E.M. CoaguLation and innate immune responses: can we view them separateLy? Blood. 2009;114(12):2367-2374. https://doi.org/10.1182/bLood-2009-05-199208.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Datsi A., Piotrowski L., Markou M., Koster T., Kohtz I., Lang K. et al. Stroke-derived neutrophils demonstrate higher formation potential and impaired resolution of CD66b + driven neutrophil extracellular traps. BMC Neurol. 2022;22(1):186. https://doi.org/10.1186/s12883-022-02707-0.</mixed-citation><mixed-citation xml:lang="en">Datsi A., Piotrowski L., Markou M., Koster T., Kohtz I., Lang K. et aL. Stroke-derived neutrophiLs demonstrate higher formation potentiaL and impaired resoLution of CD66b + driven neutrophiL extraceLLuLar traps. BMC Neurol. 2022;22(1):186. https://doi.org/10.1186/s12883-022-02707-0.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Genchi A., Semerano A., Gullotta G.S., Strambo D., Schwarz G., Bergamaschi A. et al. Cerebral thrombi of cardioembolic etiology have an increased content of neutrophil extracellular traps. J Neurol Sci. 2021;423:117355. https://doi.org/10.1016/j.jns.2021.117355.</mixed-citation><mixed-citation xml:lang="en">Genchi A., Semerano A., GuLLotta G.S., Strambo D., Schwarz G., Bergamaschi A. et aL. CerebraL thrombi of cardioemboLic etioLogy have an increased content of neutrophiL extraceLLuLar traps. J Neurol Sci. 2021;423:117355. https://doi.org/10.1016/j.jns.2021.117355.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kim S.W., Lee J.K. Role of HMGB1 in the Interplay between NETosis and Thrombosis in Ischemic Stroke: A Review. Cells. 2020;9(8):1794. https://doi.org/10.3390/cells9081794.</mixed-citation><mixed-citation xml:lang="en">Kim S.W., Lee J.K. RoLe of HMGB1 in the InterpLay between NETosis and Thrombosis in Ischemic Stroke: A Review. Cells. 2020;9(8):1794. https://doi.org/10.3390/ceLLs9081794.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mocco J., Mack WJ., Ducruet A.F., Sosunov S.A., Sughrue M.E., Hassid B.G. et al. Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res. 2006;99(2):209-217. https://doi.org/10.1161/01.RES.0000232544.90675.42.</mixed-citation><mixed-citation xml:lang="en">Mocco J., Mack WJ., Ducruet A.F., Sosunov S.A., Sughrue M.E., Hassid B.G. et aL. CompLement component C3 mediates infLammatory injury foLLowing focaL cerebraL ischemia. Circ Res. 2006;99(2):209-217. https://doi.org/10.1161/01.RES.0000232544.90675.42.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cervera A., Planas A.M., Justicia C., Urra X., Jensenius J.C., Torres F. et al. Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human stroke. PloS ONE. 2010;5(2):e8433. https://doi.org/10.1371/journal.pone.0008433.</mixed-citation><mixed-citation xml:lang="en">Cervera A., PLanas A.M., Justicia C., Urra X., Jensenius J.C., Torres F. et aL. GeneticaLLy-defined deficiency of mannose-binding Lectin is associated with protection after experimentaL stroke in mice and outcome in human stroke. PLoS ONE. 2010;5(2):e8433. https://doi.org/10.1371/journaL.pone.0008433.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Anrather J., Iadecola C. Inflammation and Stroke: An Overview. Neurotherapeutics. 2016;13(4):661-670. https://doi.org/10.1007/s13311-016-0483-x.</mixed-citation><mixed-citation xml:lang="en">Anrather J., IadecoLa C. InfLammation and Stroke: An Overview. Neurotherapeutics. 2016;13(4):661-670. https://doi.org/10.1007/s13311-016-0483-x.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Tabet A., Apra C., Stranahan A.M., Anikeeva P. Changes in Brain Neuroimmunology Following Injury and Disease. Front Integr Neurosci. 2022;16:894500. https://doi.org/10.3389/fnint.2022.894500.</mixed-citation><mixed-citation xml:lang="en">Tabet A., Apra C., Stranahan A.M., Anikeeva P. Changes in Brain NeuroimmunoLogy FoLLowing Injury and Disease. Front Integr Neurosci. 2022;16:894500. https://doi.org/10.3389/fnint.2022.894500.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gadani S.P., Walsh J.T., lukens J.R., Kipnis J. Dealing with danger in the CNS: the response of the immune system to injury. Neuron. 2015;87(1):47-62. https://doi.org/10.1016/j.neuron.2015.05.019.</mixed-citation><mixed-citation xml:lang="en">Gadani S.P., WaLsh J.T., Lukens J.R., Kipnis J. DeaLing with danger in the CNS: the response of the immune system to injury. Neuron. 2015;87(1):47-62. https://doi.org/10.1016/j.neuron.2015.05.019.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Kim E., Cho S. CNS and peripheral immunity in cerebral ischemia: partition and interaction. Exp Neurol. 2021;335:113508. https://doi.org/10.1016/j.expneurol.2020.113508.</mixed-citation><mixed-citation xml:lang="en">Kim E., Cho S. CNS and peripheraL immunity in cerebraL ischemia: partition and interaction. Exp Neurol. 2021;335:113508. https://doi.org/10.1016/j.expneuroL.2020.113508.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J Neuroimmunol. 2007;184(1-2):53-68. https://doi.org/10.1016/j.jneuroim.2006.11.014.</mixed-citation><mixed-citation xml:lang="en">Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J Neuroimmunol. 2007;184(1-2):53-68. https://doi.org/10.1016/j.jneuroim.2006.11.014.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia. 2010;58(3):253-263. https://doi.org/10.1002/glia.20928.</mixed-citation><mixed-citation xml:lang="en">Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia. 2010;58(3):253-263. https://doi.org/10.1002/glia.20928.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao S.C., Ma L.S., Chu Z.H., Xu H., Wu W.Q., Liu F. Regulation of microglial activation in stroke. Acta Pharmacol Sin. 2017;38(4):445-458. https://doi.org/10.1038/aps.2016.162.</mixed-citation><mixed-citation xml:lang="en">Zhao S.C., Ma L.S., Chu Z.H., Xu H., Wu W.Q., Liu F. Regulation of microglial activation in stroke. Acta Pharmacol Sin. 2017;38(4):445-458. https://doi.org/10.1038/aps.2016.162.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Frijns CJ, Kappelle LJ. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke. 2002;33(8):2115-2122. https://doi.org/10.1161/01.str.0000021902.33129.69.</mixed-citation><mixed-citation xml:lang="en">Frijns CJ, Kappelle LJ. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke. 2002;33(8):2115-2122. https://doi.org/10.1161/01.str.0000021902.33129.69.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Stuckey S.M., Ong L.K., Collins-Praino L.E., Turner RJ. Neuroinflammation as a Key Driver of Secondary Neurodegeneration Following Stroke? Int J Mol Sci. 2021;22(23):13101. https://doi.org/10.3390/ijms222313101.</mixed-citation><mixed-citation xml:lang="en">Stuckey S.M., Ong L.K., Collins-Praino L.E., Turner RJ. Neuroinflammation as a Key Driver of Secondary Neurodegeneration Following Stroke? Int J Mol Sci. 2021;22(23):13101. https://doi.org/10.3390/ijms222313101.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Gerhard A., Schwarz J., Myers R., Wise R., Banati R.B. Evolution of microglial activation in patients after ischemic stroke: A [11C](R)-PK11195 PET study. Neurolmage. 2005;24(2):591-595. https://doi.org/10.1016/j.neuroimage.2004.09.034.</mixed-citation><mixed-citation xml:lang="en">Gerhard A., Schwarz J., Myers R., Wise R., Banati R.B. Evolution of microglial activation in patients after ischemic stroke: A [11C](R)-PK11195 PET study. Neurolmage. 2005;24(2):591-595. https://doi.org/10.1016/j.neuroimage.2004.09.034.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Мокров Г.В., Деева О.А., Яркова М.А., Гудашева Т.А., Середенин С.Б. Трансфокаторный белок TSPO 18 кДа и его лиганды: перспективный подход к созданию новых нейропсихотропных средств. Фармакокинетика и фармакодинамика. 2018;(4):3-27. https://doi.org/10.24411/2587-7836-2018-10026.</mixed-citation><mixed-citation xml:lang="en">Mokrov G.V., Deeva O.A., YArkova M.A., Gudasheva T.A., Seredenin S.B. Translocator protein TSPO 18 kDa and its ligands: a promising approach to the creation of new neuropsychotropic drug. Pharmacokinetics and Pharmacodynamics. 2018;(4):3-27. (In Russ.) https://doi.org/10.24411/2587-7836-2018-10026.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Selvaraj U.M., Stowe A.M. Long-term T cell responses in the brain after an ischemic stroke. DiscovMed. 2017;24(134):323-333. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893311/.</mixed-citation><mixed-citation xml:lang="en">Selvaraj U.M., Stowe A.M. Long-term T cell responses in the brain after an ischemic stroke. DiscovMed. 2017;24(134):323-333. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893311/.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Черных Е.Р., Шевела Е.Я., Морозов С.А., Останин А.А. Иммунопатогенетические аспекты ишемического инсульта. Медицинская иммунология. 2018;20(1):19-34. Режим доступа: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893311/10.15789/1563-0625-2018-1-19-34.</mixed-citation><mixed-citation xml:lang="en">Chernyh E.R., Shevela E.Y., Morozov S.A., Ostanin A.A. Immunopathogenetic aspects of ischemic stroke. Medical Immunology (Russia). 2018;20(1):19-34. (In Russ.) Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC5893311/10.15789/1563-0625-2018-1-19-34.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889-896. https://doi.org/10.1038/ni.1937.</mixed-citation><mixed-citation xml:lang="en">Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11(10):889-896. https://doi.org/10.1038/ni.1937.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Klebe D., McBride D., Flores JJ., Zhang J.H., Tang J. Modulating the Immune Response Towards a Neuroregenerative Peri-injury Milieu After Cerebral Hemorrhage. J Neuroimmune Pharmacol. 2015;10(4):576-586. https://doi.org/10.1007/s11481-015-9613-1.</mixed-citation><mixed-citation xml:lang="en">Klebe D., McBride D., Flores JJ., Zhang J.H., Tang J. Modulating the Immune Response Towards a Neuroregenerative Peri-injury Milieu After Cerebral Hemorrhage. J Neuroimmune Pharmacol. 2015;10(4):576-586. https://doi.org/10.1007/s11481-015-9613-1.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Hu X., Li P., Guo Y., Wang H., Leak R.K., Chen S. et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke. 2012;43(11): 3063-3070. https://doi.org/10.1161/STROKEAHA.112.659656.</mixed-citation><mixed-citation xml:lang="en">Hu X., Li P., Guo Y., Wang H., Leak R.K., Chen S. et al. Microglia/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke. 2012;43(11): 3063-3070. https://doi.org/10.1161/STROKEAHA.112.659656.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Wang S., Zhang H., Xu Y. Crosstalk between microglia and T cells contributes to brain damage and recovery after ischemic stroke. Neurol Res. 2016;38(6):495-503. https://doi.org/10.1080/01616412.2016.1188473.</mixed-citation><mixed-citation xml:lang="en">Wang S., Zhang H., Xu Y. Crosstalk between microglia and T cells contributes to brain damage and recovery after ischemic stroke. Neurol Res. 2016;38(6):495-503. https://doi.org/10.1080/01616412.2016.1188473.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Narasimhalu K., Lee J., Leong Y.L., Ma L., De Silva D.A., Wong M.C. et al. Inflammatory markers and their association with post stroke cognitive decline. Int J Stroke. 2015;10(4):513-518. https://doi.org/10.1111/ijs.12001.</mixed-citation><mixed-citation xml:lang="en">Narasimhalu K., Lee J., Leong Y.L., Ma L., De Silva D.A., Wong M.C. et al. Inflammatory markers and their association with post stroke cognitive decline. Int J Stroke. 2015;10(4):513-518. https://doi.org/10.1111/ijs.12001.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Iadecola C., Buckwalter M.S., Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest. 2020;130(6):2777-2788. https://doi.org/10.1172/JCI135530.</mixed-citation><mixed-citation xml:lang="en">Iadecola C., Buckwalter M.S., Anrather J. Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest. 2020;130(6):2777-2788. https://doi.org/10.1172/JCI135530.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Doyle K.P., Quach L.N., Sole M., Axtell R.C., Nguyen T.V., Soler-Llavina GJ. et al. B-lymphocyte-mediated delayed cognitive impairment following stroke. J Neurosci. 2015;35(5):2133-2145. https://doi.org/10.1523/JNEUROSCI.4098-14.2015.</mixed-citation><mixed-citation xml:lang="en">Doyle K.P., Quach L.N., Sole M., Axtell R.C., Nguyen T.V., Soler-Llavina GJ. et al. B-lymphocyte-mediated delayed cognitive impairment following stroke. J Neurosci. 2015;35(5):2133-2145. https://doi.org/10.1523/JNEUROSCI.4098-14.2015.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Wanner I.B., Anderson MA., Song B., Levine J., Fernandez A., Gray-Thompson Z. et al. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J Neurosci. 2013;33(31):12870-12886. https://doi.org/10.1523/JNEUROSCI.2121-13.2013.</mixed-citation><mixed-citation xml:lang="en">Wanner I.B., Anderson MA., Song B., Levine J., Fernandez A., Gray-Thompson Z. et al. Glial scar borders are formed by newly proliferated, elongated astrocytes that interact to corral inflammatory and fibrotic cells via STAT3-dependent mechanisms after spinal cord injury. J Neurosci. 2013;33(31):12870-12886. https://doi.org/10.1523/JNEUROSCI. 2121-13.2013.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Quesseveur G., David DJ., Gaillard M.C., Pla P, Wu M.V., Nguyen H.T. et al. BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities. Transl Psychiatry. 2013;3(4):e253. https://doi.org/10.1038/tp.2013.30.</mixed-citation><mixed-citation xml:lang="en">Quesseveur G., David DJ., Gaillard M.C., Pla P, Wu M.V., Nguyen H.T. et al. BDNF overexpression in mouse hippocampal astrocytes promotes local neurogenesis and elicits anxiolytic-like activities. Transl Psychiatry. 2013;3(4):e253. https://doi.org/10.1038/tp.2013.30.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Wang X., Xuan W., Zhu Z.Y., Li Y., Zhu H., Zhu L. et al. The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke. CNS Neurosci Ther. 2018;24(12):1100-1114. https://doi.org/10.1111/cns.13077.</mixed-citation><mixed-citation xml:lang="en">Wang X., Xuan W., Zhu Z.Y., Li Y., Zhu H., Zhu L. et al. The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke. CNS Neurosci Ther. 2018;24(12):1100-1114. https://doi.org/10.1111/cns.13077.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Qiu Y.M., Zhang C.L., Chen A.Q., Wang H.L., Zhou Y.F., Li Y.N., Hu B. Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy? Front Immunol. 2021;(12):678744. https://doi.org/10.3389/fimmu.2021.678744.</mixed-citation><mixed-citation xml:lang="en">Qiu Y.M., Zhang C.L., Chen A.Q., Wang H.L., Zhou Y.F., Li Y.N., Hu B. Immune Cells in the BBB Disruption After Acute Ischemic Stroke: Targets for Immune Therapy? Front Immunol. 2021;(12):678744. https://doi.org/10.3389/fimmu.2021.678744.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Ishikawa M., Cooper D., Russell J., Salter J.W., Zhang J.H., Nanda A., Granger D.N. Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke. 2003;34(7):1777-17782. https://doi.org/10.1161/01.STR.0000074921.17767.F2.</mixed-citation><mixed-citation xml:lang="en">Ishikawa M., Cooper D., Russell J., Salter J.W., Zhang J.H., Nanda A., Granger D.N. Molecular determinants of the prothrombogenic and inflammatory phenotype assumed by the postischemic cerebral microcirculation. Stroke. 2003;34(7):1777-17782. https://doi.org/10.1161/01.STR.0000074921.17767.F2.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Angiari S., Donnarumma T., Rossi B., Dusi S., Pietronigro E., Zenaro E. et al. TIM-1 glycoprotein binds the adhesion receptor P-selectin and mediates T cell trafficking during inflammation and autoimmunity. Immunity. 2014;40(4):542-553. https://doi.org/10.1016/j.immuni.2014.03.004.</mixed-citation><mixed-citation xml:lang="en">Angiari S., Donnarumma T., Rossi B., Dusi S., Pietronigro E., Zenaro E. et al. TIM-1 glycoprotein binds the adhesion receptor P-selectin and mediates T cell trafficking during inflammation and autoimmunity. Immunity. 2014;40(4):542-553. https://doi.org/10.1016/j.immuni.2014.03.004.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Zarbock A., Ley K., McEver R.P, Hidalgo A. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood. 2011;118(26):6743-6751. https://doi.org/10.1182/blood-2011-07-343566.</mixed-citation><mixed-citation xml:lang="en">Zarbock A., Ley K., McEver R.P, Hidalgo A. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood. 2011;118(26):6743-6751. https://doi.org/10.1182/blood-2011-07-343566.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Shichita T., Sugiyama Y., Ooboshi H., Sugimori H., Nakagawa R., Takada I. et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med. 2009;15(8):946-950. https://doi.org/10.1038/nm.1999.</mixed-citation><mixed-citation xml:lang="en">Shichita T., Sugiyama Y., Ooboshi H., Sugimori H., Nakagawa R., Takada I. et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med. 2009;15(8):946-950. https://doi.org/10.1038/nm.1999.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Gelderblom M., Weymar A., Bernreuther C., Velden J., Arunachalam P, Steinbach K. et al. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood. 2012;120(18):3793-3802. https://doi.org/10.1182/blood-2012-02-412726.</mixed-citation><mixed-citation xml:lang="en">Gelderblom M., Weymar A., Bernreuther C., Velden J., Arunachalam P, Steinbach K. et al. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood. 2012;120(18):3793-3802. https://doi.org/10.1182/blood-2012-02-412726.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Vindegaard N., Munoz-Briones C., El Ali H.H., Kristensen l.K., Rasmussen R.S., Johansen F.F., Hasseldam H. T-cells and macrophages peak weeks after experimental stroke: Spatial and temporal characteristics. Neuropathology 2017;37(5):407-414. https://doi.org/10.1111/neup.12387.</mixed-citation><mixed-citation xml:lang="en">Vindegaard N., Munoz-Briones C., El Ali H.H., Kristensen L.K., Rasmussen R.S., Johansen F.F., Hasseldam H. T-cells and macrophages peak weeks after experimental stroke: Spatial and temporal characteristics. Neuropathology 2017;37(5):407-414. https://doi.org/10.1111/neup.12387.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Miro-Mur F., Urra X., Ruiz-Jaen F., Pedragosa J., Chamorro A., Planas A.M. Antigen-Dependent T Cell Response to Neural Peptides After Human Ischemic Stroke. Front Cell Neurosci. 2020;(14):206. https://doi.org/10.3389/fncel.2020.00206.</mixed-citation><mixed-citation xml:lang="en">Miro-Mur F., Urra X., Ruiz-Jaen F., Pedragosa J., Chamorro A., Planas A.M. Antigen-Dependent T Cell Response to Neural Peptides After Human Ischemic Stroke. Front Cell Neurosci. 2020;(14):206. https://doi.org/10.3389/fncel.2020.00206.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Gu L., Xiong X., Zhang H., Xu B., Steinberg G.K., Zhao H. Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice. Stroke. 2012;43(7):1941-1946. https://doi.org/10.1161/STROKEAHA.112.656611.</mixed-citation><mixed-citation xml:lang="en">Gu L., Xiong X., Zhang H., Xu B., Steinberg G.K., Zhao H. Distinctive effects of T cell subsets in neuronal injury induced by cocultured splenocytes in vitro and by in vivo stroke in mice. Stroke. 2012;43(7):1941-1946. https://doi.org/10.1161/STROKEAHA.112.656611.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Gu L., Jian Z., Stary C., Xiong X. T Cells and Cerebral Ischemic Stroke. Neurochem Res. 2015;40(9):1786-1791. https://doi.org/10.1007/s11064-015-1676-0.</mixed-citation><mixed-citation xml:lang="en">Gu L., Jian Z., Stary C., Xiong X. T Cells and Cerebral Ischemic Stroke. Neurochem Res. 2015;40(9):1786-1791. https://doi.org/10.1007/s11064-015-1676-0.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Wang L., Yao C., Chen J., Ge Y., Wang C., Wang Y. et al. y5 T Cell in Cerebral Ischemic Stroke: Characteristic, Immunity-Inflammatory Role, and Therapy. Front Neurol. 2022;(13):842212. https://doi.org/10.3389/fneur.2022.842212.</mixed-citation><mixed-citation xml:lang="en">Wang L., Yao C., Chen J., Ge Y., Wang C., Wang Y. et al. y5 T Cell in Cerebral Ischemic Stroke: Characteristic, Immunity-Inflammatory Role, and Therapy. Front Neurol. 2022;(13):842212. https://doi.org/10.3389/fneur.2022.842212.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Hermann D.M., Kleinschnitz C., Gunzer M. Role of polymorphonuclear neutrophils in the reperfused ischemic brain: insights from cell-type-specific immunodepletion and fluorescence microscopy studies. Ther Adv Neurol Disord. 2018;11:1756286418798607. https://doi.org/10.1177/1756286418798607.</mixed-citation><mixed-citation xml:lang="en">Hermann D.M., Kleinschnitz C., Gunzer M. Role of polymorphonuclear neutrophils in the reperfused ischemic brain: insights from cell-type-specific immunodepletion and fluorescence microscopy studies. Ther Adv Neurol Disord. 2018;11:1756286418798607. https://doi.org/10.1177/1756286418798607.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Ni P, Dong H., Wang Y., Zhou Q., Xu M., Qian Y., Sun J. IL-17A contributes to perioperative neurocognitive disorders through blood-brain barrier disruption in aged mice. J Neuroinflammation. 2018;15(1):332. https://doi.org/10.1186/s12974-018-1374-3.</mixed-citation><mixed-citation xml:lang="en">Ni P, Dong H., Wang Y., Zhou Q., Xu M., Qian Y., Sun J. IL-17A contributes to perioperative neurocognitive disorders through blood-brain barrier disruption in aged mice. J Neuroinflammation. 2018;15(1):332. https://doi.org/10.1186/s12974-018-1374-3.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Zhu F., Wang O., Guo C., Wang X., Cao X., Shi Y. et al. IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome. Clin Immunol. 2011;141(2):152-160. https://doi.org/10.1016/j.clim.2011.07.003.</mixed-citation><mixed-citation xml:lang="en">Zhu F., Wang O., Guo C., Wang X., Cao X., Shi Y. et al. IL-17 induces apoptosis of vascular endothelial cells: a potential mechanism for human acute coronary syndrome. Clin Immunol. 2011;141(2):152-160. https://doi.org/10.1016/j.clim.2011.07.003.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Clarkson B.D., Ling C., Shi Y., Harris M.G., Rayasam A., Sun D. et al. T cell-derived interleukin (IL)-21 promotes brain injury following stroke in mice. J Exp Med. 2014;211(4):595-604. https://doi.org/10.1084/jem.20131377.</mixed-citation><mixed-citation xml:lang="en">Clarkson B.D., Ling C., Shi Y., Harris M.G., Rayasam A., Sun D. et al. T cell-derived interleukin (IL)-21 promotes brain injury following stroke in mice. J Exp Med. 2014;211(4):595-604. https://doi.org/10.1084/jem.20131377.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Dong Y., Hu C., Huang C., Gao J., Niu W., Wang D. et al. Interleukin-22 Plays a Protective Role by Regulating the JAK2-STAT3 Pathway to Improve Inflammation, Oxidative Stress, and Neuronal Apoptosis following Cerebral Ischemia-Reperfusion Injury. Mediators Inflamm. 2021;2021:6621296. https://doi.org/10.1155/2021/6621296.</mixed-citation><mixed-citation xml:lang="en">Dong Y., Hu C., Huang C., Gao J., Niu W., Wang D. et al. Interleukin-22 Plays a Protective Role by Regulating the JAK2-STAT3 Pathway to Improve Inflammation, Oxidative Stress, and Neuronal Apoptosis following Cerebral Ischemia-Reperfusion Injury. Mediators Inflamm. 2021;2021:6621296. https://doi.org/10.1155/2021/6621296.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Gan Y., Liu Q., Wu W., Yin J.X., Bai X.F., Shen R. et al. Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc Natl Acad Sci USA. 2014;111(7):2704-2709. https://doi.org/10.1073/pnas.1315943111.</mixed-citation><mixed-citation xml:lang="en">Gan Y., Liu Q., Wu W., Yin J.X., Bai X.F., Shen R. et al. Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc Natl Acad Sci USA. 2014;111(7):2704-2709. https://doi.org/10.1073/pnas.1315943111.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Q., Jin W.N., Liu Y., Shi K., Sun H., Zhang F. et al. Brain Ischemia Suppresses Immunity in the Periphery and Brain via Different Neurogenic Innervations. Immunity 2017;46(3):474-487. https://doi.org/10.1016/j.immuni.2017.02.015.</mixed-citation><mixed-citation xml:lang="en">Liu Q., Jin W.N., Liu Y., Shi K., Sun H., Zhang F. et al. Brain Ischemia Suppresses Immunity in the Periphery and Brain via Different Neurogenic Innervations. Immunity 2017;46(3):474-487. https://doi.org/10.1016/j.immuni.2017.02.015.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Voskoboinik I., Whisstock J.C., Trapani J.A. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 2015;15(6):388-400. https://doi.org/10.1038/nri3839.</mixed-citation><mixed-citation xml:lang="en">Voskoboinik I., Whisstock J.C., Trapani J.A. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 2015;15(6):388-400. https://doi.org/10.1038/nri3839.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Chu H.X., Kim H.A., Lee S., Moore J.P., Chan C.T., Vinh A. et al. Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia. J Cereb Blood Flow Metab. 2014;34(3):450-459. https://doi.org/10.1038/jcbfm.2013.217.</mixed-citation><mixed-citation xml:lang="en">Chu H.X., Kim H.A., Lee S., Moore J.P., Chan C.T., Vinh A. et al. Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia. J Cereb Blood Flow Metab. 2014;34(3):450-459. https://doi.org/10.1038/jcbfm.2013.217.</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Chaitanya G.V., Eeka P., Munker R., Alexander J.S., Babu P.P. Role of cytotoxic protease granzyme-b in neuronal degeneration during human stroke. Brain Pathol. 2011;21(1):16-30. https://doi.org/10.1111/j.1750-3639.2010.00426.x.</mixed-citation><mixed-citation xml:lang="en">Chaitanya G.V., Eeka P., Munker R., Alexander J.S., Babu P.P. Role of cytotoxic protease granzyme-b in neuronal degeneration during human stroke. Brain Pathol. 2011;21(1):16-30. https://doi.org/10.1111/j.1750-3639.2010.00426.x.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Liesz A., Hu X., Kleinschnitz C., Offner H. Functional role of regulatory lymphocytes in stroke: facts and controversies. Stroke. 2015;46(5):1422-1430. https://doi.org/10.1161/STROKEAHA.114.008608.</mixed-citation><mixed-citation xml:lang="en">Liesz A., Hu X., Kleinschnitz C., Offner H. FunctionaL role of regulatory lymphocytes in stroke: facts and controversies. Stroke. 2015;46(5):1422-1430. https://doi.org/10.1161/STROKEAHA.114.008608.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Khantakova J.N., Bulygin A.S., Sennikov S.V. The Regulatory-T-Cell Memory Phenotype: What We Know. Cells. 2022;11(10):1687. https://doi.org/10.3390/cells11101687.</mixed-citation><mixed-citation xml:lang="en">Khantakova J.N., Bulygin A.S., Sennikov S.V. The Regulatory-T-Cell Memory Phenotype: What We Know. Cells. 2022;11(10):1687. https://doi.org/10.3390/cells11101687.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Jayaraj R.L., Azimullah S., Beiram R., Jalal F.Y., Rosenberg G.A. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142. https://doi.org/10.1186/s12974-019-1516-2.</mixed-citation><mixed-citation xml:lang="en">Jayaraj R.L., Azimullah S., Beiram R., Jalal F.Y., Rosenberg G.A. Neuroinflammation: friend and foe for ischemic stroke. J Neuroinflammation. 2019;16(1):142. https://doi.org/10.1186/s12974-019-1516-2.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Liesz A., Zhou W., Na S.Y., Hammerling GJ., Garbi N., Karcher S. et al. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. J Neurosci. 2013;33(44):17350-17362. https://doi.org/10.1523/JNEUROSCI.4901-12.2013.</mixed-citation><mixed-citation xml:lang="en">Liesz A., Zhou W., Na S.Y., Hammerling GJ., Garbi N., Karcher S. et al. Boosting regulatory T cells limits neuroinflammation in permanent cortical stroke. J Neurosci. 2013;33(44):17350-17362. https://doi.org/10.1523/JNEUROSCI.4901-12.2013.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Protti G.G., Gagliardi RJ., Forte W.C., Sprovieri S.R. Interleukin-10 may protect against progressing injury during the acute phase of ischemic stroke. Arq Neuropsiquiatr. 2013;71(11):846-851. https://doi.org/10.1590/0004-282X20130168.</mixed-citation><mixed-citation xml:lang="en">Protti G.G., Gagliardi RJ., Forte W.C., Sprovieri S.R. Interleukin-10 may protect against progressing injury during the acute phase of ischemic stroke. Arq Neuropsiquiatr. 2013;71(11):846-851. https://doi.org/10.1590/0004-282X20130168.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Ooboshi H., Ibayashi S., Shichita T., Kumai Y, Takada J., Ago T. et al. Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation. 2005;111(7):913-919. https://doi.org/10.1161/01.CIR.0000155622.68580.DC.</mixed-citation><mixed-citation xml:lang="en">Ooboshi H., Ibayashi S., Shichita T., Kumai Y, Takada J., Ago T. et al. Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation. 2005;111(7):913-919. https://doi.org/10.1161/01.CIR.0000155622.68580.DC.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Xie L., Choudhury G.R., Winters A., Yang S.H., Jin K. Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol. 2015;45(1):180-191. https://doi.org/10.1002/eji.201444823.</mixed-citation><mixed-citation xml:lang="en">Xie L., Choudhury G.R., Winters A., Yang S.H., Jin K. Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10. Eur J Immunol. 2015;45(1):180-191. https://doi.org/10.1002/eji.201444823.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Ramiro L., Simats A., Garcia-Berrocoso T., Montaner J. Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management. Ther Adv Neurol Disord. 2018;11:1756286418789340. https://doi.org/10.1177/1756286418789340.</mixed-citation><mixed-citation xml:lang="en">Ramiro L., Simats A., Garcia-Berrocoso T., Montaner J. Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management. Ther Adv Neurol Disord. 2018;11:1756286418789340. https://doi.org/10.1177/1756286418789340.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Maida C.D., Norrito R.L., Daidone M., Tuttolomondo A., Pinto A. Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches. Int J Mol Sci. 2020;21(18):6454. https://doi.org/10.3390/ijms21186454.</mixed-citation><mixed-citation xml:lang="en">Maida C.D., Norrito R.L., Daidone M., Tuttolomondo A., Pinto A. Neuroinflammatory Mechanisms in Ischemic Stroke: Focus on Cardioembolic Stroke, Background, and Therapeutic Approaches. Int J Mol Sci. 2020;21(18):6454. https://doi.org/10.3390/ijms21186454.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Monson N.L., Ortega S.B., Ireland SJ., Meeuwissen AJ., Chen D., Plautz EJ. et al. Repetitive hypoxic preconditioning induces an immunosuppressed B cell phenotype during endogenous protection from stroke. J Neuroinflammation. 2014;(11):22. https://doi.org/10.1186/1742-2094-11-22.</mixed-citation><mixed-citation xml:lang="en">Monson N.L., Ortega S.B., Ireland SJ., Meeuwissen AJ., Chen D., Plautz EJ. et al. Repetitive hypoxic preconditioning induces an immunosuppressed B cell phenotype during endogenous protection from stroke. J Neuroinflammation. 2014;(11):22. https://doi.org/10.1186/1742-2094-11-22.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Esen N., Rainey-Barger E.K., Huber A.K., Blakely P.K., Irani D.N. Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. Glia. 2014;62(9):1452-1462. httpsv7doi.org/10.1002/glia.22692.</mixed-citation><mixed-citation xml:lang="en">Esen N., Rainey-Barger E.K., Huber A.K., Blakely P.K., Irani D.N. Type-I interferons suppress microglial production of the lymphoid chemokine, CXCL13. Glia. 2014;62(9):1452-1462. httpsv7doi.org/10.1002/glia.22692.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Pitzalis C., Jones G.W., Bombardieri M., Jones S.A. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol. 2014;14(7):447-462. https://doi.org/10.1038/nri3700</mixed-citation><mixed-citation xml:lang="en">Pitzalis C., Jones G.W., Bombardieri M., Jones S.A. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat Rev Immunol. 2014;14(7):447-462. https://doi.org/10.1038/nri3700</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Doyle K.P., Buckwalter M.S. Does B lymphocyte-mediated autoimmunity contribute to post-stroke dementia? Brain Behav Immun. 2017;(64):1-8. https://doi.org/10.1016/j.bbi.2016.08.009.</mixed-citation><mixed-citation xml:lang="en">Doyle K.P., Buckwalter M.S. Does B lymphocyte-mediated autoimmunity contribute to post-stroke dementia? Brain Behav Immun. 2017;(64):1-8. https://doi.org/10.1016/j.bbi.2016.08.009.</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Kim E., Cho S. CNS and peripheral immunity in cerebral ischemia: partition and interaction. Exp Neurol. 2021;(335):113508. https://doi.org/10.1016/j.expneurol.2020.113508.</mixed-citation><mixed-citation xml:lang="en">Kim E., Cho S. CNS and peripheral immunity in cerebral ischemia: partition and interaction. Exp Neurol. 2021;(335):113508. https://doi.org/10.1016/j.expneurol.2020.113508.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Seifert H.A., Vandenbark AA., Offner H. Regulatory B cells in experimental stroke. Immunology. 2018;154(2):169-177. https://doi.org/10.1111/imm.12887.</mixed-citation><mixed-citation xml:lang="en">Seifert H.A., Vandenbark AA., Offner H. Regulatory B cells in experimental stroke. Immunology. 2018;154(2):169-177. https://doi.org/10.1111/imm.12887.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
